Harvard's David M. Nathan, M.D., to speak as Visiting Professor April 18
As part of the Taubman Institute's visiting professor program, eminent endocrinologist David M. Nathan, M.D., of Harvard University will deliver two lectures at the University of Michigan Health System on April 18.
Dr. Nathan, an internationally recognized expert on diabetes and its complications, will first address Internal Medicine Grand Rounds at noon in Ford Auditorium. His presentation is titled, “The Type 2 Diabetes Epidemic: Prevention and Therapy.”
Later the same afternoon at 2 p.m., Dr. Nathan will present “Diabetes Trials and Tribulations in 2014: What do we know?” at the Division of Metabolism, Endocrinology & Diabetes (MEND) Combined Clinical/Research Conference and Diabetes Grand Rounds.
The Taubman Institute regularly collaborates with other University of Michigan Medical School departments to invite distinguished thought leaders in medical research to speak on the U-M campus in Ann Arbor. The lectures are generally held monthly and represent the Taubman Institute's ongoing commitment to furthering translational medical research by creating opportunities for the most talented physician-researchers to exchange knowledge and ideas.
Stem cell symposium set for Sept. 19 in Ann Arbor
Dr. Eva Feldman will be among the speakers at the one-day event, which focuses on cutting-edge developments in stem-cell biology, epigenetics and regneratrive medicine.
Click here for details and registration.
New U-M President visits Taubman Institute
The Institute hosted a fellow clinician-scientist when the University of Michigan’s new president paid a visit to the A. Alfred Taubman Biomedical Science Research Building.
People who care
Institute welcomes new gift officer
Maria Muller has been appointed to work with connect donors with funding opportunities at the Taubman Institute.
Click here to read more.
news & events
Institute symposium set for Oct. 10
The A. Alfred Taubman Medical Research Institute will award the 2014 $100,000 Taubman Prize for Excellence in Translational Medical Science at its 7th annual symposium at 10 a.m. on Oct. 10.
Dr. Carl June, a physician-scientist who developed a personalized immunotherapy for leukemia using patients’ own T cells, will receive the honor and deliver the symposium's keynote address.
Click here for symposium details.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.